High Quality 99% Purity Idra-21 22503-72-6 Nootropic Powder

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: 22503-72-6
• Product Name: Idra-21
• Colour: White
• CAS No.: 22503-72-6
• Mf: C8h9cln2o2s
• MW: 232.69
• Shelf Time: 2 Years
• Transport Package: Dry and Cool
• Specification: 1kg/Aluminum Foil Bag, 25kg/Cardboard Drum
• Trademark: Gina
• Origin: Shaanxi, China
• Production Capacity: 10000 Kilogram/ Month

Product Description

IDRA-21 is a relatively new nootropic compound.   It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by  orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
IDRA-21 is classified as an ampakine. It is able to improve focus and attention as well as promote learning and memory. Ampakines are growing in popularity largely because they provide the cognitive benefits of stimulants without the undesirable side effects.

Product name	IDRA 21
CAS No.	22503-72-6
MF	C8H9ClN2O2S
MW	232.69
Melting point	209 °C(Solv: acetic acid )
Boiling point	405.1±55.0 °C(Predicted)
Density	1.394±0.06 g/cm3(Predicted)
Storage	Keep in dark place,Inert atmosphere,Room temperature

 

1. Idra-21 can increases in cognition.
2. Idra-21 can increased Task Accuracy.
3. Idra-21 can increase in Short Term Memory.
4. Idra-21 has potential Therapeutic Effects On Schizophrenia.
5. Idra-21 has potential Therapeutic Effects On Depression.
6. Idra-21 has neuroprotection.